Identifying proteomic risk factors for overall, aggressive, and early onset prostate cancer using Mendelian Randomisation and tumour spatial transcriptomics.
Desai TA, Hedman ÅK, Dimitriou M, Koprulu M, Figiel S, Yin W, Johansson M, Watts EL, Atkins JR, Sokolov AV, Schiöth HB, Gunter MJ, Tsilidis KK, Martin RM, Pietzner M, Langenberg C, Mills IG, Lamb AD, Mälarstig A, Key TJ; PRACTICAL Consortium; Travis RC, Smith-Byrne K.
Desai TA, et al. Among authors: yin w.
EBioMedicine. 2024 Jun 14;105:105168. doi: 10.1016/j.ebiom.2024.105168. Online ahead of print.
EBioMedicine. 2024.
PMID: 38878676